In a population-based study, Yan et al. reported that RBP4 plasma levels were inversely correlated with the insulin secretion function of β-cells in female patients with non-alcoholic fatty liver disease [117]. Here, RBP4 is linked to metabolic dysfunction-associated steatotic liver disease.